B

Belluscura PLC
LSE:BELL

Watchlist Manager
Belluscura PLC
LSE:BELL
Watchlist
Price: 10.375 GBX 1.22%
Market Cap: 17.5m GBX
Have any thoughts about
Belluscura PLC?
Write Note

Intrinsic Value

The intrinsic value of one BELL stock under the Base Case scenario is 11.114 GBX. Compared to the current market price of 10.375 GBX, Belluscura PLC is Undervalued by 7%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

BELL Intrinsic Value
11.114 GBX
Undervaluation 7%
Intrinsic Value
Price
B
Worst Case
Base Case
Best Case

Valuation Backtest
Belluscura PLC

Backtest Intrinsic Value
Dive into the past to invest in the future

Uncover deeper insights with the Valuation Backtest. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start backtest now and learn if your stock is truly undervalued or overvalued!

Run Backtest
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Backtest Unavailable

The backtest for BELL cannot be conducted due to limitations such as insufficient data or other constraints. Please select a different stock or adjust your settings.

Backtest In Progress...
Backtest In Progress...
How do you feel about BELL?
Bearish
Neutral
Bullish
Discover Undervalued Stocks
Health Care Industry

Fundamental Analysis

Risks & Rewards

 

 

 

 

View All Risks & Rewards
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Notes
AI Assistant
AI Assistant
Ask me anything about Belluscura PLC

Provide an overview of the primary business activities
of Belluscura PLC.

What unique competitive advantages
does Belluscura PLC hold over its rivals?

What risks and challenges
does Belluscura PLC face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Belluscura PLC.

Provide P/S
for Belluscura PLC.

Provide P/E
for Belluscura PLC.

Provide P/OCF
for Belluscura PLC.

Provide P/FCFE
for Belluscura PLC.

Provide P/B
for Belluscura PLC.

Provide EV/S
for Belluscura PLC.

Provide EV/GP
for Belluscura PLC.

Provide EV/EBITDA
for Belluscura PLC.

Provide EV/EBIT
for Belluscura PLC.

Provide EV/OCF
for Belluscura PLC.

Provide EV/FCFF
for Belluscura PLC.

Provide EV/IC
for Belluscura PLC.

Show me price targets
for Belluscura PLC made by professional analysts.

What are the Revenue projections
for Belluscura PLC?

How accurate were the past Revenue estimates
for Belluscura PLC?

What are the Net Income projections
for Belluscura PLC?

How accurate were the past Net Income estimates
for Belluscura PLC?

What are the EPS projections
for Belluscura PLC?

How accurate were the past EPS estimates
for Belluscura PLC?

What are the EBIT projections
for Belluscura PLC?

How accurate were the past EBIT estimates
for Belluscura PLC?

Compare the revenue forecasts
for Belluscura PLC with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Belluscura PLC and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Belluscura PLC against its competitors.

Analyze the profit margins
(gross, operating, and net) of Belluscura PLC compared to its peers.

Compare the P/E ratios
of Belluscura PLC against its peers.

Discuss the investment returns and shareholder value creation
comparing Belluscura PLC with its peers.

Analyze the financial leverage
of Belluscura PLC compared to its main competitors.

Show all profitability ratios
for Belluscura PLC.

Provide ROE
for Belluscura PLC.

Provide ROA
for Belluscura PLC.

Provide ROIC
for Belluscura PLC.

Provide ROCE
for Belluscura PLC.

Provide Gross Margin
for Belluscura PLC.

Provide Operating Margin
for Belluscura PLC.

Provide Net Margin
for Belluscura PLC.

Provide FCF Margin
for Belluscura PLC.

Show all solvency ratios
for Belluscura PLC.

Provide D/E Ratio
for Belluscura PLC.

Provide D/A Ratio
for Belluscura PLC.

Provide Interest Coverage Ratio
for Belluscura PLC.

Provide Altman Z-Score Ratio
for Belluscura PLC.

Provide Quick Ratio
for Belluscura PLC.

Provide Current Ratio
for Belluscura PLC.

Provide Cash Ratio
for Belluscura PLC.

What is the historical Revenue growth
over the last 5 years for Belluscura PLC?

What is the historical Net Income growth
over the last 5 years for Belluscura PLC?

What is the current Free Cash Flow
of Belluscura PLC?

Discuss the annual earnings per share (EPS)
trend over the past five years for Belluscura PLC.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Belluscura PLC

Balance Sheet Decomposition
Belluscura PLC

Current Assets 9.4m
Cash & Short-Term Investments 875.7k
Receivables 5.2m
Other Current Assets 3.4m
Non-Current Assets 12.1m
PP&E 260.6k
Intangibles 10.9m
Other Non-Current Assets 976.3k
Current Liabilities 2.9m
Accounts Payable 2.9m
Non-Current Liabilities 34.9k
Other Non-Current Liabilities 34.9k
Efficiency

Earnings Waterfall
Belluscura PLC

Revenue
1.8m USD
Cost of Revenue
-2.4m USD
Gross Profit
-600.7k USD
Operating Expenses
-11.4m USD
Operating Income
-12m USD
Other Expenses
-6.6m USD
Net Income
-18.6m USD

Free Cash Flow Analysis
Belluscura PLC

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

BELL Profitability Score
Profitability Due Diligence

Belluscura PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

Exceptional 1-Year Revenue Growth
Negative Operating Income
Negative Net Income
Negative ROE
17/100
Profitability
Score

Belluscura PLC's profitability score is 17/100. The higher the profitability score, the more profitable the company is.

BELL Solvency Score
Solvency Due Diligence

Belluscura PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Long-Term Solvency
Low D/E
Short-Term Solvency
Low Altman Z-Score
65/100
Solvency
Score

Belluscura PLC's solvency score is 65/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

BELL Price Targets Summary
Belluscura PLC

Wall Street analysts forecast BELL stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for BELL is 35.7 GBX with a low forecast of 35.35 GBX and a high forecast of 36.75 GBX.

Lowest
Price Target
35.35 GBX
241% Upside
Average
Price Target
35.7 GBX
244% Upside
Highest
Price Target
36.75 GBX
254% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for BELL?

Click here to dive deeper.

Dividends

Belluscura PLC
does not pay dividends
Shareholder Yield

Current shareholder yield for BELL is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Profile

Belluscura PLC

Country

United Kingdom

Industry

Health Care

Market Cap

16.7m GBP

Dividend Yield

0%

Description

Belluscura Plc engages in the provision of medical devices. The Company’s product, the X-PLO2R, is a lightweight portable oxygen concentrator (POC), which is designed to replace larger, metal oxygen tanks and heavier portable oxygen concentrator devices. The company focuses on devices and treatments involving oxygen. The X-PLO2R DX is designed to produce approximately six-liters pulse dose oxygen and approximately two-liters of flow oxygen. The firm is focused on developing the medical devices for treating people who are suffering from chronic lung diseases, such as the chronic obstructive pulmonary disease (COPD), respiratory distress caused by coronavirus disease (COVID-19), and other respiratory disorders.

Contact

London
15 Fetter Lane
www.belluscura.com

IPO

2021-05-28

Employees

11

Officers

CEO & Director
Mr. Robert Rauker
CFO & Director
Mr. Simon Neicheril
Senior Vice President of Global Sales & Executive Director
Mr. Robert Fary
Company Secretary
Mr. Anthony Stephen Dyer FMCA
Vice President of Operations
Mr. Keith Cook
Head of Commercial Strategy
Mr. Jim Clement

See Also

Discover More
What is the Intrinsic Value of one BELL stock?

The intrinsic value of one BELL stock under the Base Case scenario is 11.114 GBX.

Is BELL stock undervalued or overvalued?

Compared to the current market price of 10.375 GBX, Belluscura PLC is Undervalued by 7%.

Back to Top